Early Promising Data From the Phase 1 Clinical Trial of the Vaxine’s COVID-19 Vaccine

The Phase 1 trial of COVAX-19®, the Australian COVID-19 vaccine developed by Vaxine Pty Ltd, was independently conducted by the PARC clinical trial team, a University of Adelaide based research group. The study was started on June 30, 2020, at the Royal Adelaide Hospital and included 40 healthy participants aged between 18 and 65 years. […]